- Home
- SYRE vs NSIT Comparison
SYRE vs NSIT Comparison
Compare SYRE & NSIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYRE | NSIT |
|---|---|---|
| Founded | 2013 | 1988 |
| Country | United States | United States |
| Employees | N/A | 14505 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | 2015 | 1996 |
Fundamental Metrics
Financial Performance| Metric | SYRE | NSIT |
|---|---|---|
| Price | $43.49 | $83.19 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 4 |
| Target Price | $55.57 | ★ $118.75 |
| AVG Volume (30 Days) | ★ 655.8K | 401.9K |
| Earning Date | 05-19-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 4.86 |
| Revenue | N/A | ★ $8,247,180,000.00 |
| Revenue This Year | N/A | $4.28 |
| Revenue Next Year | N/A | $2.05 |
| P/E Ratio | ★ N/A | $17.38 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.91 | $77.10 |
| 52 Week High | $45.76 | $160.72 |
Technical Indicators
Market Signals| Indicator | SYRE | NSIT |
|---|---|---|
| Relative Strength Index (RSI) | 71.28 | 47.86 |
| Support Level | $14.62 | $78.94 |
| Resistance Level | N/A | $88.08 |
| Average True Range (ATR) | 2.29 | 3.81 |
| MACD | 0.74 | -0.30 |
| Stochastic Oscillator | 79.60 | 19.06 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About NSIT Insight Enterprises Inc.
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, government agencies, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital workplace, cloud/data center transformation, IT modernization, Cyber Security and supply chain optimization solutions and services.